|
|
市场分析报告
|
Enzastaurin (CAS 359017-79-1) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Global Market Report of Enzastaurin (CAS 170364-57-5) December 2024
CAS 170364-57-5 Enzastaurin Chemical Report & Database ... Report & Database definitions: Name: Enzastaurin: Enzastaurin; LY 317615; 3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmethyl)-4-piperidinyl ... APPLICATIONS: Chemical or Reaction Intermediate The Enzastaurin Report & Database gives Market Consumption ...
DB-102 - Emerging Insight and Market Forecast - 2030 ... other emerging therapies. OVERVIEW DB102 (enzastaurin) is an orally available investigational first-in-class ...
Global Glioblastoma Multiforme Treatment Market Size study, by Treatment (Surgery Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Fields Therapy, Immunotherapy), by Drug class (Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Others), by End use (Hospitals, Clinics, Ambulatory Surgical Centres), and Regional Forecasts 2021-2027 ... for designation to Denovo biopharma’s DB102 (enzastaurin) to treat new patients who are ...
Proto oncogene protein c-akt inhibitors - Pipeline Insight, 2022 ... Paxalisib Tucidinostat Capivasertib Miransertib Afuresertib Enzastaurin CU 05 API-2 Pravitinib Uprosertib ALM 301 ...
Ehlers-Danlos Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major Ehlers-Danlos syndrome markets are expected to exhibit a CAGR of 3.42% during 2024-2034. The Ehlers-Danlos syndrome market has been comprehensively analyzed in IMARC's new report titled "Ehlers-Danlos Syndrome Market: Epidemiology, Industry ...
|
|
|
|